Phillip Securities Group
·q½Ð¯d·N¡A¼Ú¬w®L¥O®É¶¡±N©ó¥|¤ë¤@¤é¹ê¦æ¡A¦Ó¬ü°ê«h©ó¤T¤ë¤Q¤@¤é¹ê¦æ¡A©Ò¦³¦³Ãö¸Ó¥æ©ö©Òªº¦X¬ù¶R½æ®É¶¡±N·|´£«e¤@¤p®É¡A¦p¦³¥ô¦ó¬d¸ß¡A½Ð­P¹q½L©Ð22776677¡C¥~¶×¬ü¤¸/¤é¤¸¡A¶R½æ®t»ù§C¦Ü¤@ÂI¡C¸Ô±¡½Ð«ö¦¹¡C ¤é¸g´Á³f±N·|¥[«öª÷¦Ü¦X¬ù»ù­Èªº¦Ê¤À¤§¤­¡A§Y¤é¥Í®Ä¡A¸Ô±¡½Ð­P¹q22776677¡C

28-03-2024(¬P´Á¥|) 27-03-2024(¬P´Á¤T) 26-03-2024(¬P´Á¤G) 25-03-2024(¬P´Á¤@) 22-03-2024(¬P´Á¤­)
­¶¼Æ : 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 |
½÷¥ß¬ã¨s³¡§Ö°T
¬d¬Ý©õ¤é¬ã¨s³¡§Ö°T Âà±Hµ¹ªB¤Í §K¶O­q¾\ ·N¨£´£¨Ñ English Version
Phillip Home   11¤ë30¤é (¬P´Á¤T)

 

­»´äÂå«äÂåÀø¶°¹Î(2138)
¸Ñºc¡G
­»´äÂå«äÂåÀø(2138)¬°­»´ä³Ì¤jªºÂå¾Ç¬ü®eªA°È´£¨Ñ°Ó¡A¥D­n±Mª`©ó´£¨ÑÂå¾Ç¬ü®eªA°È¡A¦p¾ã«¬¥~¬ì¤â³N¡B·L¾ã§ÎÀøµ{¤ÎÂå¥Í¾Þ§@ªº¯à¶qÀu¾¹Àøµ{¡CºI¦Ü9¤ë©³¤î¤W¥b¦~«×¡A¶°¹Î¹ê²{Á`¦¬¯q4.07»õ´ä¤¸¡A¦P¤ñ¼Wªø21.4%¡CºJ°£ªÑ¥÷¼úÀy¤ÎÁʪÑÅv¶}¤ä¥H¤Î¹ñ·s°·±dºÞ²z·~°Èªì©l¸ê¥»¤ä¥X¤À§O¬°1140¸U¤¸©M4230¸U¤¸¡A¸g½Õ¾ãªÑªFÀ³¦û¯Â§Q¬°1.14»õ¤¸¡A¸û¥h¦~¦P´Áªº9640¸U¤¸(ºJ°£¤W¥«¶O¥Î¶}¤ä1290¸U¤¸)¼Wªø18.8%¡C¶°¹Î¤w©ó¤º¦a¥ý«á¶}³]¨â®aÂå¾Ç¬ü®e¶E©Ò¡A¥¼¨Ó±N©ó¤¤°ê¤@½u¤Î¿ï©w¤G½u«°¥«Ä~ÄòÂX¤jÂå¾Ç¬ü®e¶E©Ò¡C(µ§ªÌ¨S¦³«ù¦³¤W­zªÑ²¼)
µ¦²¤¡G
¶R¤J»ù$2.55¡A¥Ø¼Ð»ù$2.80¡A¤î»k»ù$2.40
 

¸fÂ×Àô«O(1381)
¸Ñºc¡G
2016¤W¥b¦~¸fÂ×Àô«O¹ê²{¦¬¤J6.7»õ´ä¤¸¡A¦P¤ñ´£¤É37.8%¡AªÑªFÀ³¥e§Q¼í1.54»õ¤¸¡A¦P¤ñ¼Wªø52.5%¡A¨CªÑ¬Õ§Q7.7´ä¥P¡A¦P¤ñ¼Wªø54%¡C¨ãÅé¦Ó¨¥¡A±o¯q©ó¬ì°¶µI¿Nµo¹q¼t§Þ³N§ï³y«áªºÀç¹B°^Äm¡A°â¹q¤Î©U§£³B²z¶O¦¬¤J°^Äm¤F¥D­n¼Wªø¡A¨ä¦¬¤J«ö¦~¼Wªø50.7%¦Ü3.75»õ¤¸¡A¨ä¦¸¬OBOT«Ø³]¦¬¤J«ö¦~¼Wªø19.5%¦Ü2.79»õ¤¸¡C§Ú­Ì«ùÄò¬Ý¦n¥¼¨Ó2-3¦~©U§£µI¿N¦æ·~ªºµo®i«e´º¡A¦b¤@¤G½u«°¥«¤×¨ä¬O¤T¥|½u«°¥«©U§£µI¿N³B²z¶q¤´¦³¸û¤jªº¼WªøªÅ¶¡¡C¦Ó¥B¤½¥q±M®×Àò¨ú¯à¤O±j¡A§Þ³N§ï³y¸gÅçÂ×´I¡A¹ï¦¬ÁʱM®×¶i¦æ§Þ§ïÂX®e±N¤ä¼µ¬Õ§Q¯à¤O¤£Â_¼W±j¡C§Ú­Ìµ¹¤©¤½¥q2017¦~24­¿P/E¡A¹ïÀ³¥Ø¼Ð»ù4.56´ä¤¸¡Aºû«ù¡§¶R¤J¡¨µû¯Å¡C
µ¦²¤¡G
¶R¤J»ù$3.63¡A¥Ø¼Ð»ù$4.56¡A¤î»k»ù$3.30
¤HºÖÂåÃÄ (600079.CH) - »s¾¯¥X¤f©Î¤ä¼µ·~ÁZÃzµo
¤HºÖÂåÃÄ«e¤T©u«×¹ê²{¦¬¤J87.8»õ¤¸¡A¦P¤ñ¼W26.6%¡AÂk¥À²b§Q¼í6.2»õ¤¸¡A¦P¤ñ¼W41.2%¡A¥D­n±o¯q©óEPIC Pharmµ¥¨Ãªíªº¼vÅT¡C­ç°£EPIC²b§Q¼í¡B¨ÃÁʶO¥Î¥H¤Î·s¼W°]°È¶O¥Î«á¡A½Õ¾ã«á¦©«DÂk¥À²b§Q¼í¬°4.7»õ¤¸¡A«ö¦~13.6%¡A²Å¦X¤½¥q¤º¥Í¼W³t¬ù15%ªº¹w´Á¡C......§ó¦h

¬Fµ¦¥[½X¬°³q¥Î¯èªÅ¥[³tµo®i«O¾rÅ@¯è

¨Æ¥ó¡G°ê®aµo§ï©eªñ¤é¬ÛÄ~µo§G¤F¡mªñ´Á±À¶i³q¥Î¯èªÅ·~µo®iªº­«ÂI¥ô°È¡n¡A¡mÃö©ó°µ¦n³q¥Î¯èªÅ¥Ü½d±À¼s¦³Ãö¤u§@ªº³qª¾¡n¡A¦w±Æ³¡¸p¤F°ö¨|³q¥Î¯èªÅ¥«³õ¡B¥[§Ö³q¥Î¾÷³õ«Ø³]¡B«P¶i²£·~¤É¯Å¡BÂX¤j§CªÅªÅ°ì¶}©ñ©M±j¤Æ¥þµ{¦w¥þºÊºÞ¤­¤j¥ô°È¤Uªº¦@­p21 ¶µ­«ÂI¤u§@¡F´£¥X½Ñ¦......§ó¦h


  • 29¤é¡A¥¡¦æ¦A¶}®i1900»õ¤¸°f¦^Áʾާ@¡A¥]¬A900»õ¤¸7¤Ñ´Á¡B700»õ¤¸14¤Ñ´Á©M300»õ¤¸28¤Ñ´Á¡F¦bºû«ù7¤Ñ´Á°f¦^ÁÊ¥æ©ö¶q¤j­Pí©wªº¦P®É¡A¥¡¦æ¼W¥[¤F´Á­­µyªøªº14¤Ñ©M28¤Ñ´Á°f¦^ÁÊ¥æ©ö¶q¡A¥Hº¡¨¬¥«³õ¾÷ºc¤£Â_¼W¥[ªº¸ó¤ë¸êª÷»Ý¨D¡C¤£¹L¡A·í¤é°f¦^ÁÊ¥æ©ö¶q¤´¤£¤Î2000»õ¤¸ªº¨ì´Á¦^Å¢¶q¡A¦¹¦¸¾Þ§@²b¦^Å¢100»õ¤¸¡A¬°11¤ë24¤é¥H¨Óªº³sÄò²Ä¥|¦¸²b¦^Å¢¡C
  • °ê»Ú°]¸g
    • ¬ü°ê¤T©u«×¹ê»ÚGDP¦~¤Æ©uÀô¤ñ­×¥¿­È3.2%¡A¹w´Á3%¡Aªì­È2.9%¡C¬ü°ê¤T©u«×­Ó¤H®ø¶O¤ä¥X(PCE)¦~¤Æ©uÀô¤ñ­×¥¿­È2.8%¡A¹w´Á2.3%¡Aªì­È2.1%¡C¬ü°ê¤T©u«×GDP¥­´î«ü¼Æ­×¥¿­È1.4%¡A¹w´Á1.5%¡Aªì­È1.5%¡C¬ü°ê¤T©u«×®Ö¤ß­Ó¤H®ø¶O¤ä¥X(PCE)ª«»ù«ü¼Æ¦~¤Æ©uÀô¤ñ­×¥¿­È1.7%¡A¹w´Á1.7%¡Aªì­È1.7%¡C¬ü°êGDP­×¥¿­È¦n©ó¹w´Á¡A¬ü¤¸«ü¼Æ¡B10¦~´Á¬ü¶Å¦¬¯q²vµu½u¤W´­¡A¶Àª÷¤U¶^¡C
  • ¥D­nÉ]³õ
    • ¶g¤G¨È¤ÓªÑ¥«º¦¶^¤¬²{¡A¨ä¤¤¤é¥»ªÑ¥«¤é¸g225«ü¼Æ¤U¶^0.27%¡A³ø18307.04ÂI;¤é¥»ªFÃҪѻù«ü¼Æ¤U¶^0.07%¡A³ø1468.57ÂI¡C¦]¤é¤¸¤Wº¦·l¤Î¤H®ð¡A¤é¸g225«ü¼Æ¤µ¤é¸òÀH¹j©]¬üªÑ¤U¶^¡A³B©ó®z¶Õ¾_Àú®æ§½¡C
  • Àô²yºîµû
    • ¬ü°êªÑ¥«¶g¤G¤p´T¦¬°ª¡A¦]UnitedHealthªº¼ÖÆ[°]´ú´£®¶ÂåÀø«OÀIÃþªÑ¡A¦ýªo»ù«æ®À­«À£¯à·½ªÑ¡A¥Oº¦´T¨ü­­¡C¹Dã¤u·~«ü¼Æ¦¬°ª23.70ÂI¡A©Î0.12%¡A¦Ü19¡A121.60ÂI¡F¼Ð·Ç´¶º¸500«ü¼Æ¦¬¤É2.94ÂI¡A©Î0.13%¡A¦Ü2¡A204.66ÂI¡C¯Ç´µ¹F§J«ü¼Æ¦¬°ª11.11ÂI¡A©Î0.21%¡A¦Ü5¡A379.92ÂI¡A¦¹«e³Ð¤U¬ö¿ý½L¤¤°ª¦ì¡C
    • ¬ü¤¸³s¶^¨â¤é«á¡A³¡¤Àµu½u§ë¾÷©ÊªÅÀY¥­­Üµ²§Q¡A­Ý¤§¥«³õ¤´¤¤½u¬Ý¦h¬ü¤¸«ü¼Æ¡A¶g¤G¬ü¤¸«ü¼Æ±q§CÂI¦^¤É¡A¨ê·s¤é°ª101.49¡A³Ì²×³ø100.958ÂI¡C¬ü¤¸¨«±j¥O¥H¨ä­p»ùªº¶Qª÷ÄÝ©ÓÀ£¡C

    ¥«ªp¤ÀªR¡GCOMEX 12¤ë´Áª÷¶g¤G¤U¶^2.9¬ü¤¸¡A¶^´T0.23%¡A³ø1187.9¬ü¤¸/¯s¥q¡C¥Ñ©ó¥þ²y¸gÀÙ¼Wªø¦³©Ò§ïµ½¡A§ë¸êªÌ­·ÀI±¡ºü¦^Âk¡A§ó«C·ý­·ÀI¸ê²£¦pªÑ¥«µ¥¡C¬ü¤¸¤]Ä~Äò¨ü¨ì¬üÁpÀx12¤ë¥[®§¹w´Áªº¤ä¼µ¡A¬ü¤¸ªº¤Wº¦¨Ï±o¹ï«D¬ü³f¹ô«ù¦³ªÌªº¶R®a¨Ó»¡¡A¤j©v°Ó«~·|Åã±o©ù¶Q¡C¤é¤º¤½§Gªº¸ê®Æ¹ï¶Àª÷ºc¦¨¸û¤jÀ£¤O¡A¸ê®ÆÅã¥Ü¬ü°ê¤T©u«×GDP¼W³t³Ð¹O¨â¦~·s°ª¡F¬ü°ê11¤ë®ø¶OªÌ«H¤ß«ü¼Æ¤]¤É¦Ü2007¦~7¤ë¨Ó³Ì°ª¡F¾¨ºÞ¬ü°ê²Ä¤T©u­Ó¤H®ø¶O¤ä¥X(PCE)ª«»ù«ü¼Æ¤£¤Î¹w¦ô¡C...... §ó¦h

    ¤¤»È­»´ä (2388.HK)
    ¬ã¨s³ø§i: ¤¤»È­»´ä(2388.HK)¥Ø¼Ð»ù33.00´ä¤¸¡C¤¤»È­»´ä¤§¥D­n·~°È¬°´£¨Ñ»È¦æ¤Î¬ÛÃö¤§ª÷¿ÄªA°È¡C¶°¹Î¤W¥b¦~²b§Q®§¦¬¤J¬°121.72»õ´ä¤¸¡A¸û¥h¦~¦P´Á´î¤Ö11.20 »õ´ä¤¸©Î8.4%¡A¥D­n¬O²b®§®t¤U­°©Ò­P¡C²b®§®t«ö¦~¦¬¯¶27 ­Ó°òÂI¦Ü1.29%¡A¥D­n¨ü¨ì¤H¥Á¹ô¥«³õ§Q²v¤U¶^¡B¤µ¦~²Ä¤@©u«×ªøµu´Á§Q²v­Ë±¾¡A¥[¤W²Mºâ¦æ·~°Èªº¤H¥Á¹ô¸êª÷¼W¥[¡A¾É­P¤H¥Á¹ô·~°Èªº¥­§¡§Q®t¤U­°©ì²Ö¡C¸ê²£¤è­±¡A¶°¹Î¥­§¡¥Í®§¸ê²£¼W¥[10.1%¦Ü18,953.00»õ´ä¤¸¡A¥D­n¥Ñ©ó«È¤á¦s´Ú¡B»È¦æ¦s´Ú¤Îµ²¾l¤W¤É¡F¸ê²£¼Wªø«ö¥b¦~­p¿ý14%¼W´T¡A«H¶U«ö¥b¦~¼Wªø11%¡A¶W¹L¥»´ä¦P·~¤ô¥­¡C¤¤»Èªº´¶³qªÑÅv¤@¯Å¸ê¥»¤ñ²vÀò¤j´T´£¤É¡C¶°¹Î¤W¥b¦~ªÑªFÀ³¦û·¸§Q«ö¦~¼Wªø2.2 ­¿¦Ü427.31»õ´ä¤¸¡A§é¦X¨CªÑ°ò¥»¬Õ§Q¬°4.0416 ´ä¤¸¡C´Á¤º¥­§¡ªÑªFÅv¯q¦^³ø²v¥Ñ2015¦~¦P´Áªº14.78%¼W¥[¦Ü25.90%¡C¥t¥~¡A¸³¨Æ·|«Øij¬£µo¤¤´ÁªÑ®§¤Î¯S§OªÑ®§¦X¦@¨CªÑ1.2550´ä¤¸¡A¨ä¤¤¡A2015¦~¤¤»È­»´ä¥þ°âºX¤U«n°ÓªÑÅv¤©¤¤°ê«H¹F(1359.HK)ªþÄÝ«H¹Fª÷±±¡A±a¨Ó¬ù340»õ´ä¤¸ªºµ|«e¦¬¯q¡A¥H¦¹¬£µo¯S§OªÑ®§0.71´ä¤¸¡A¤¤´Á®§0.545´ä¤¸¡A¬£®§²vºû«ù¦b45%¡C¦³´CÅé³ø¹D¡A¤¤»È­»´ä±N¦V·Hªù°ê»Ú»È¦æ¥X°â¶°¤Í»È¦æ70%ªºªÑÅv¡A¦ô­È30»õ¬ü¤¸¬ù¦X234»õ´ä¤¸¡A©¡®É¶°¹Î±N¥i®M²{164»õ´ä¤¸¡C§Ú­Ì»{¬°¡A¦pªG¨óij¹F¦¨¡A¤¤»È­»´ä±N§ó§Ö±À¶i¤H¥Á¹ô°ê»Ú¤Æ¥Ø¼Ð¤Uªº¤@±a¤@¸ô¾Ô²¤¡A¤Î°t¦X¤º¦a¸gÀ٧ﭲ¨B¥ï¥[§Ö¡A±N¬°¤½¥q±a¨Ó·sªº°Ó¾÷¡A¦Ó²`´ä³qªñ´ÁÀò§å¡A¥ç¬O¤@­Ó§Q¦n¦]¯À¡C


    ¥«ªp¤ÀªR¡G¶g¤G¨È¤ÓªÑ¥«º¦¶^¤¬²{¡A¨ä¤¤¤é¥»ªÑ¥«¤é¸g225«ü¼Æ¤U¶^0.27%¡A³ø18307.04ÂI;¤é¥»ªFÃҪѻù«ü¼Æ¤U¶^0.07%¡A³ø1468.57ÂI¡C¦]¤é¤¸¤Wº¦·l¤Î¤H®ð¡A¤é¸g225«ü¼Æ¤µ¤é¸òÀH¹j©]¬üªÑ¤U¶^¡A³B©ó®z¶Õ¾_Àú®æ§½¡C......§ó¦h

    ¥»¦a«ü¼Æ
           ÂI¼Æ    ¤É¶^   ¤É¶^%

    Àô²y«ü¼Æ
           ÂI¼Æ    ¤É¶^   ¤É¶^%

    A-H·¸»ù(§éÅý) ªí
    ¥N¸¹ ¤½¥q¦WºÙ H ªÑ
    ¦¬¥«»ù
    A ªÑ
    ¦¬¥«»ù
    A - H
    ·¸»ù

    ¨ä¥L
       ÂI¼Æ     ¤É¶^   ¤É¶^%
      
      


    ®ü¥~¬ã¨s³ø§i


    §ë¸êªA°È¤¤¤ß


    ¬d¸ß¼ö½u¡G2277 6666 ©Î investornotes@phillip.com.hk
    ¦pªG­¶­±Åã¥Ü¤£¥¿±`½ÐÂIÀ» ¦¹³B¬d¬Ý³sµ²©ó¸Uºûºô¤Wªºª©¥»¡C
     

    Phillip Research - Hong Kong ½÷¥ß¬ã¨s³¡ ¡V ­»´ä¤Î¤¤°ê
    ¤½¥q ªÑ²¼½s¸¹ ³Ì«á§ó·s¤é´Á «Øij ¥Ø¼Ð»ù «Øij®ÉªÑ»ù
    ¸ê°T¬ì§Þ ¬ã¨s³¡ (N/A+852 2277 6527)research@phillip.com.hk
    ©ù¯Ç¬ì§Þ87727/09/2016¼ÈµLµû¯Å4.02
    ©ù¯Ç¥ú³q«H87726/10/2010¶R¤J7.156
    ¥æ³q¤Î¨T¨® ³¹´¹ ((86) 2151699200-103)zhangjing@phillip.com.cn
    ¤W¨T¶°¹Î60010425/11/2016¼W«ù25.8123.65
    ¼s¨T¶°¹Î223818/11/2016¶R¤J12.79.22
    «OÀI ¬ã¨s³¡ ((86) 21 51699400-110)research@phillip.com.cn
    ±¸ª÷²`ªÑ³q07/11/2016µLµû¯Å
    ±¸ª÷²`ªÑ³q : ¦æ·~·§Äý02/11/2016µLµû¯Å
    ¶Ç´C¤Î¦L¨ê ¬ã¨s³¡  ((+ 86 21 51699400-107))research@phillip.com.cn
    ´¼¬üÅé¨|166111/07/2016¶R¤J3.32.18
    ºôÀs77716/06/2016¶R¤J28.422.9
    ÂåÃÄ ÖË°ê©M ((+ 86 21 51699400-110))fanguohe@phillip.com.cn
    ¤HºÖÂåÃÄ60007930/11/2016¶R¤J26.9520.19
    µØ¼íÂùÅb60006223/11/2016¼W«ù27.5223.08
    «O°·Å@²z¥Î«~ ÖË°ê©M ((+ 86 21 51699400-110))fanguohe@phillip.com.cn
    ¥Õ¶³¤s87418/10/2016¶R¤J24.4819.16
    ¥Õ¶³¤s87417/10/2016¶R¤J24.4819.16
    ·s¯à·½ ¬ã¨s³¡ ((86) 21 51699400-110)research@phillip.com.cn
    ¨ó¦X·s¯à·½18224/10/2016¶R¤J0.60.39
    ¿³·~¤Ó¶§¯à75014/10/2016¶R¤J5.14.12
    ­¹ª«¶¼«~¤Î¹s°â ¬ã¨s³¡ ((86) 21 51699400-110)research@phillip.com.cn
    361«×136126/08/2016¶R¤J3.22.48
    «O§Q¤å¤Æ363625/08/2016¼W «ù23.519.84
    ¹q°T ÖË°ê©M (+ (86) 21 51699400-110)fanguohe@phillip.com.cn
    ¤¤°ê³nÅé°ê»Ú35426/10/2016¶R¤J4.863.72
    ¤¤°ê³nÅé°ê»Ú35425/10/2016¶R¤J4.863.72
    ¤º¦a©Ð¦a²£ªÑ ¬ã¨s³¡ ((86) 21 51699400-110)research@phillip.com.cn
    ¦X´º®õ´I181324/11/2016¶R¤J5.94.38
    Às¥ú¦a²£338008/11/2016¼ÈµLµû¯Å3.1
    ¤½¥Î¨Æ·~ ¬ã¨s³¡ ((86) 21 51699400-110)research@phillip.com.cn
    ±d¹FÀô«O613629/11/2016¶R¤J2.381.94
    ±d¹FÀô«O613628/11/2016¶R¤J2.381.94
    ³n¥óªA°È ¬ã¨s³¡ ((86) 21 51699400-110)research@phillip.com.cn
    ª÷¨¹¹FÄ_¹Å±±ªÑ331518/02/2015N/A4.77
    IGG800221/11/2014¼W«ù3.953.44
    °s©±¤Î®T¼Ö ³¹´¹ ((+ 86 51699400-103))zhangjing@phillip.com.cn
    ÀA¦¿°s©±200608/07/2016¼W«ù2.982.49
    °ê®ÈÁp¦X60035808/03/2016N/A10.41

    ¥»¤å©Ò¥]§tªº¸ê®Æ§¡¬°½÷¥ßµý¨é(­»´ä)¦³­­¤½¥q©Î¨äªþÄݤ½¥q (¡u¶°¹Î¡v) ±q¬Û«H¬°·Ç½Tªº¨Ó·½·j¶°¡A¦ý¹ï¥ô¦ó¦]«H¿à©Î°Ñ¦Ò¦³Ãö¤º®e©Ò¾É­Pªº·l¥¢¡A·§¤£­t³d¡C¥»¶°¹Î (©Î¨ä¹µ­û) ¥i¯à«ù¦³¥»¤å©Ò­z¦³Ãöªº§ë¸ê²£«~¡C¦UÃþ²£«~ªº­·ÀI¡A½Ð°Ñ¾\¥»¤½¥qºô­¶ http://www.phillip.com.hk¡m­·ÀI©ÜÅSÁn©ú¡n¡C

    ¦p±z¤£·Q¦A¦¬¨ú¹q¤l±À¼s¶l¥ó¡A½Ð«ö¦¹³B¡C

    ª©Åv©Ò¦³¡A ½¦L¥²¨s¡C

    Copyright(C) 2016 Phillip Securities (HK) Ltd. All Rights Reserved.


    Copyright © 2011 ½÷ ¥ß µý ¨é ¶° ¹Î ¡C ª© Åv ©Ò ¦³ [ ­·ÀI©ÜÅSÁn©ú ] [ ±ø´Ú¤Î²Ó«h ] [ ­Ó¤H¸ê®Æ¦¬¶°Án©ú ]